If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Anton Peleg is Professor of Infectious Diseases and Microbiology and Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University. He is also a research group leader in the Department of Microbiology, Monash University. His research spans clinical to basic research, with a focus on hospital-acquired infections, antimicrobial resistance, infections in immunocompromised hosts and understanding mechanisms of disease caused by hospital pathogens. He has a particular clinical interest in complex infections in highly vulnerable patient groups, including patients with cystic fibrosis, lung and stem cell transplant recipients, and infections in patients with burns or in intensive care.

Clinical activities

Infectious Diseases Physician, Alfred Hospital, Melbourne VIC

Keywords

  • antibiotic prescribing
  • antibiotic resistance
  • antimicrobial stewardship
  • qualitative research
  • resi
  • bacteria
  • candida
  • epidemiology
  • hematopoietic stem cell transplantation
  • infection
  • microbial drug
  • diabetes
  • immunity
  • glycaemic control
  • hospital-acquired infections
  • antimicrobial resistance
  • infections in immunocompromised hosts

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2022

Research Output 2004 2019

Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation

Jiang, J-H., Bhuiyan, M. S., Shen, H-H., Cameron, D. R., Rupasinghe, T. W. T., Wu, C. M., Le Brun, A. P., Kostoulias, X., Domene, C., Fulcher, A. J., McConville, M. J., Howden, B. P., Lieschke, G. J. & Peleg, A. Y., 26 Feb 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 9, p. 3722-3727 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Identification of Novel Acinetobacter baumannii Host Fatty Acid Stress Adaptation Strategies

Jiang, J. H., Hassan, K. A., Begg, S. L., Rupasinghe, T. W. T., Naidu, V., Pederick, V. G., Khorvash, M., Whittall, J. J., Paton, J. C., Paulsen, I. T., McDevitt, C. A., Peleg, A. Y. & Eijkelkamp, B. A., 5 Feb 2019, In : mBio. 10, 1, 6 p., e02056-18.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Oxa-23 is a prevalent mechanism contributing to sulbactam resistance in diverse acinetobacter baumannii clinical strains

Yang, Y., Xu, Q., Li, T., Fu, Y., Shi, Y., Lan, P., Zhao, D., Chen, Q., Zhou, Z., Jiang, Y., Peleg, A. Y. & Yu, Y., 1 Jan 2019, In : Antimicrobial Agents and Chemotherapy. 63, 1, 4 p., e01676-18.

Research output: Contribution to journalLetterOtherpeer-review

Comprehensive antibiotic-linked mutation assessment by resistance mutation sequencing (RM-seq)

Guérillot, R., Li, L., Baines, S., Howden, B., Schultz, M. B., Seemann, T., Monk, I., Pidot, S. J., Gao, W., Giulieri, S., Gonçalves da Silva, A., D'Agata, A., Tomita, T., Peleg, A. Y., Stinear, T. P. & Howden, B. P., 31 Aug 2018, In : Genome Medicine. 10, 1, 15 p., 63.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
File

Convergent evolution driven by rifampin exacerbates the global burden of drug-resistant Staphylococcus aureus

Guérillot, R., da Silva, A. G., Monk, I., Giulieri, S., Tomita, T., Alison, E., Porter, J., Pidot, S., Gao, W., Peleg, A. Y., Seemann, T., Stinear, T. P. & Howden, B. P., 1 Jan 2018, In : mSphere. 3, 1, e00550-17.

Research output: Contribution to journalArticleResearchpeer-review

Activities 2017 2017

  • 1 Membership of industry collaboration/ network

Monash Biomedicine Discovery Institute (Organisational unit)

Trevor Lithgow (Inventor), Matthew James Belousoff (Member), Meredith Anne O'Keeffe (Member), Max Cryle (Member), Ana Traven (Member), John Dallas Boyce (Member), Julian Ian Rood (Member), Fasseli Joseph Coulibaly (Member), Anton Yariv Peleg (Member), Sheena McGowan (Member), Dena Lyras (Member), Philip Robert Heraud (Member)
20172018

Activity: Industry, Government and Philanthropy Engagement and PartnershipsMembership of industry collaboration/ network